The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres

Journal of Microencapsulation

Volumn 23, Issue 8, 2006, Pages 832-843

  Determan, Amy S ^a   Graham, Jennifer R ^a   Pfeiffer, Katherine A ^a   Narasimhan, Balaji ^a  

^a Iowa State University of Science and Technology   (United States)

Author keywords

Cryogenic atomization; Ovalbumin; Polyanhydrides; s o o; w o o; w o w

Indexed keywords

ACID ANHYDRIDE; MICROSPHERE; OVALBUMIN; POLYANHYDRIDE; SEBACIC ACID; WATER OIL CREAM;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EMULSION; ENCAPSULATION; GEL ELECTROPHORESIS; PROTEIN SECONDARY STRUCTURE; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TRANSPORT;

ANIMALS; CAPSULES; CHICKENS; DRUG CARRIERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; KINETICS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; OVALBUMIN; POLYANHYDRIDES; POLYMERS; PROTEIN STRUCTURE, SECONDARY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 33644747670     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040601033841     Document Type: Article

References (41)

1. Alonso, MJ,.Cohen, S.,.Park, TG,.Gupta, RK,.Siber, GR and Langer, R. (1993) Determinants of release rate of tetanus vaccine from polyester microspheres. Pharmaceutical Research, 10, pp. 945-953.
2. Bilati, U.,.Allemann, E. and Doelker, E. (2005) Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. European Journal of Pharmaceutics and Biopharmaceutics, 59, pp. 375-388.
3. Carrasquillo, KG,.Carro, JCA,.Alejandro, A.,.Diaz, D. and Griebenow, K. (2001) Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation. Journal of Pharmacy and Pharmacology, 53, pp. 115-120.
4. Carrasquillo, KG,.Stanley, AM,.Aponte-Carro, JC,.De Jesus, P.,.Costantino, HR,.Bosques, CJ and Griebenow, K. (2001) Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. Journal of Controlled Release, 76, pp. 199-208.
5. Castellanos, IJ,.Carrasquillo, KG,.Lopez, JDJ,.Alvarez, M. and Griebenow, K. (2001) Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique. Journal of Pharmacy and Pharmacology, 53, pp. 167-178.
6. Chen, J-L,.Chiang, C-H and Yeh, M-K (2002) The mechanism of PLA microparticle formation by water-in-oil-in-water solvent evaporation method. Journal of Microencapsulation, 19, pp. 333-346.
7. Cho, SW,.Song, SH and Choi, YW (2000) Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin. Archives of Pharmacal Research, 23, pp. 385-390.
8. Conix, A. (1966) Poly[1,3-bis(p-carboxyphenoxy)propane anhydride]. Macromolecular Synthesis, 2, pp. 95-98.
9. Determan, A.,.Wilson, JH,.Kipper, MJ,.Wannemuehler, MJ and Narasimhan, B. (2006) Protein stability in the presence of polymer degradation products: Consequences for controlled release formulations. Biomaterials, 27, pp. 3312-3320.
10. Determan, AS and Narasimhan, B. (2005) Engineering surface-erodible polyanhydrides with tailored microstructure for controlled drug and protein delivery. Handbook of nanostructured biomaterials and their applications in nanotechnology, pp. 108-141. American Scientific Publishers, Stevenson Ranch
11. Determan, AS,.Trewyn, BG,.Lin, VS-Y,.Nilsen-Hamilton, M. and Narasimhan, B. (2004) Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres. Journal of Controlled Release, 100, pp. 97-109.
12. Domb, AJ and Langer, R. (1989) Solid-state and solution stability of poly(anhydrides) and poly(esters). Macromolecules, 22, pp. 2117-2122.
13. Dong, A.,.Meyer, JD,.Brown, JL,.Manning, MC and Carpenter, JF (2000) Comparative Fourier transform infrared and circular dichroism spectroscopic analysis of alpha1-proteinase inhibitor and ovalbumin in aqueous solution. Archives of Biochemistry and Biophysics, 383, pp. 148-155.
14. Esparza, I. and Kissel, T. (1992) Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine, 10, pp. 714-720.
15. Griebenow, K.,.Hsieh, L.,.Klibanov, A. and Langer, R. (1999) FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. Journal of Controlled Release, 58, pp. 357-366.
16. Gombotz, WR,.Healy, MS and Brown, LR (1899) United States Patent.
17. Griebenow, K. and Klibanov, AM (1899) Lyophilization-induced reversible changes in the secondary structure of proteins. Proceedings of the National Academy of Sciences (USA) 92:10969-10976
18. Griebenow, K. and Klibanov, AM (1996) On protein denaturation in aqueous-organic mixtures but not in pure solvents. Journal of American Chemical Society, 118, pp. 11695-11700.
19. Hanes, J.,.Chiba, M. and Langer, R. (1998) Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery. Biomaterials, 19, pp. 163-172.
20. Kipper, MJ (2004) Engineering bioerodible polymers with tailored micro/ nanostructure for vaccine delivery., Department of Chemical Engineering, Ames, Iowa State University
21. Kipper, MJ,.Seifert, S.,.Thiyagarajan, P. and Narasimhan, B. (2004) Understanding the phase behavior of biodegradable polyanhydride blends using scattering, microscopy, and molecular simulations. Polymer, 45, pp. 3329-3340.
22. Kipper, MJ,.Shen, E.,.Determan, A. and Narasimhan, B. (2002) Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. Biomaterials, 23, pp. 4405-4412.
23. Kipper, MJ,.Wilson, JH,.Wannemuehler, MJ and Narasimhan, B. (2006) Single dose tetanus vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. Journal of Biomedical Materials Research, 76, pp. 798-810.
24. Lam, XM,.Duenas, ET,.Daugherty, AL,.Levin, N. and Cleland, JL (2000) Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. Journal of Controlled Release, 67, pp. 281-292.
25. Leong, KW,.D'Amore, P.,.Marletta, M. and Langer, R. (1986) Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. Journal of Biomedical Materials Research, 20, pp. 51-64.
26. Narasimhan, B. and Kipper, MJ (2004) Surface-erodible biomaterials for drug delivery. Advanced Chemical Engineering, 29, pp. 169-218.
27. Peters, TJ (1996) All about albumin, Academic Press, San Diego
28. Putney, SD (1998) Encapsulation of proteins for improved delivery. Current opinion in Chemical Biology, 2, pp. 548-552.
29. Ron, E.,.Mathiowitz, E.,.Mathiowitz, G.,.Domb, A. and Langer, R. (1991) NMR characterization of erodible copolymers. Macromolecules, 24, p. 2278.
30. Sah, H. (1999) Protein behavior at the water/methylene chloride interface. Journal of Pharmaceutical Sciences, 88, pp. 1320-1325.
31. Sah, H. (1999) Protein instability toward organic solvent/water emulsification: Implications for protein microencapsulation into microspheres. PDA Journal of Pharmaceutical Science & Technology, 53, pp. 3-10.
32. Sah, H. (1999) Stabilization of proteins against methylene chloride/ water interface-induced denaturation and aggregation. Journal of Controlled Release, 58, pp. 143-151.
33. Shen, E.,.Kipper, MJ,.Dziadul, B.,.Lim, M-K and Narasimhan, B. (2002) Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides. Journal of Controlled Release, 82, pp. 115-125.
34. Shen, E.,.Pizsczek, R.,.Dziadul, B. and Narasimhan, B. (2001) Microphase separation in bioerodible copolymers for drug delivery. Biomaterials, 22, pp. 201-210.
35. Stein, PE,.Leslie, AGW,.Finch, JT and Carrell, RW (1991) Crystal structure of uncleaved ovalbumin at 1.95A resolution. Journal of Molecular Biology, 221, pp. 941-959.
36. Sun, SW,.Jeong, YI,.Jung, SW and Kim, SH (2003) Characterization of FITC-albumin encapsulated poly(-lactide-co-glycolide) microspheres and its release characteristics. Journal of Microencapsulation, 20, pp. 479-488.
37. Tabata, Y.,.Gutta, S. and Langer, R. (1993) Controlled delivery systems for proteins using polyanhydride microspheres. Pharmaceutical Research, 10, pp. 487-496.
38. Tamada, Y. and Langer, R. (1992) The development of polyanhydrides for drug delivery applications. Biomaterial Science Polymer Edition, 3, pp. 315-353.
39. van de Weert, M.,.Hoechstetter, J.,.Hennink, WE and Crommelin, DJA (2000) The effect of a water/organic solvent interface on the structural stability of lysozyme. Journal of Controlled Release, 68, pp. 351-359.
40. Yang, Y-Y,.Chung, T-S and Ng, NP (2001) Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/ evaporation method. Biomaterials, 22, pp. 231-241.
41. Yeh, M-K,.Coombes, AGA,.Jenkins, PG and Davis, SS (1995) A novel emulsification-solvent extraction technique for production of protein loaded biodegradable microparticles for vaccine and drug delivery. Journal of Controlled Release, 33, pp. 437-445.